Which T cells cause psoriasis?

Clinical and Experimental Dermatology

Volumn 24, Issue 4, 1999, Pages 291-295

  Prinz, J C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNE DISEASE; HUMAN; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN DISEASE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; KERATINOCYTES; LYMPHOCYTE ACTIVATION; PHARYNGITIS; PSORIASIS; RECEPTORS, ANTIGEN, T-CELL; STREPTOCOCCAL INFECTIONS; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0032769690     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1999.00483.x     Document Type: Review

References (35)

1. 1 Mueller W, Hermann B. Cyclosporin A for psoriasis. N Engl J Med 1976; 301: 355.
2. 2 Henseler T. The genetics of psoriasis. J Am Acad Dermatol 1997; 37: S1-11.
3. 3 Trembath RC, Clough RL, Rosbotham JL et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997; 6: 815-20.
4. 4 Tomfohrde J, Silverman A, Barnes R et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994; 264: 1141-5.
5. 5 Michel G, Kemény L, Homey B, Ruzicka T. FK506 in the treatment of inflammatory skin disease: promises and perspectives. Immunol Today 1996; 17: 106-8.
6. 6 Weinshenker BG, Bass BH, Ebers GC, Rice GP. Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment. J Am Acad Dermatol 1989; 20: 1132-3.
7. 7 Prinz JC, Braun-Falco O, Meurer M et al. Chimeric CD4 monoclonal antibody in the treatment of generalized pustular psoriasis. Lancet 1991; 338: 320-1.
8. 8 Nicolas JF, Chamchick N, Thivolet J et al. CD4 antibody treatment of severe psoriasis. Lancet 1991; 338: 321.
9. 389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med 1995; 1: 442-7.
10. 10 Kaplan A, Matsue H, Shibaki A et al. The effects of cyclosporin A and FK506 on proliferation and IL-8 production of cultured human keratinocytes. J Dermatol Sci 1995; 10: 130-8.
11. 11 Bos JD, Zonneveld I, Das PK et al. The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 1987; 88: 569-73.
12. 12 Prinz JC, Gross B, Vollmer S et al. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro. Eur J Immunol 1994; 24: 593-8.
13. 13 Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest 1995; 95: 317-27.
14. 14 Wrone Smith T, Nickoloff BJ. Dermal injection of immunocytes induces psoriasis [see comments]. J Clin Invest 1996; 98: 1878-87.
15. 15 Nickoloff BJ, Basham TY, Merigan TC. The antiproliferative effects of recombinant alpha and gamma interferon on normal and cultured human keratinocytes. Lab Invest 1984; 51: 697-701.
16. 16 Bjerke JR, Livden JK, Degre M, Matre R. Interferon in suction blister fluids from psoriasis lesions. Br J Dermatol 1983; 108: 295-300.
17. 17 Uyemura K, Yamamura M, Fivenson DF et al. The cytokine network in lesional and lesional-free psoriatic skin is characterized by a T helper type 1 cell-mediated response. J Invest Dermatol 1993; 101: 701-5.
18. 18 Schlaak JF, Buslau M, Jochum W et al. T cells involved in psoriasis belong to the TH1 subset. J Invest Dermatol 1994; 102: 145-9.
19. 19 Vollmer S, Menssen A, Trommler P et al. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 1994; 24: 2377-82.
20. + T cells in psoriatic lesions preferentially use T-cell receptor Vb3 and/ orVb1 3.1 genes. Proc Natl Acad Sci USA 1994; 91: 9282-6.
21. 21 Menssen A, Trommler P, Vollmer S et al. Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 1995; 155: 4078-83.
22. 22 Leung DY, Travers JB, Giorno R et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995; 96: 2106-12.
23. 23 Valdimarsson H, Baker BS, Jonsdottir I et al. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995; 16: 145-9.
24. 24 Marguerie C, Lunardi C, So A. PCR-based analysis of the TCR repertoire in human autoimmune diseases. Immunol Today 1992; 13: 336-8.
25. 25 Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition [published erratum appears in Nature 1988; 335: 744]. Nature 1988; 334: 395-402.
26. 25 Davis MM, Bjorkman PJ. T-cell antigen receptor genesand T-cell recognition [published erratum appears inNature 1988; 335: 744]. Nature 1988; 334: 395-402.
27. 26 Lafaille JJ, DeCloux A, Bonneville M et al. Junctional sequences of T cell receptor gamma delta genes: implications for gamma delta T cell lineages and for a novel intermediate of V-(D) -J joining. Cell 1989; 59: 859-70.
28. 27 Kappler J, Kotzin B, Herron L et al. V beta-specific stimulation of human T cells by staphylococcal toxins. Science 1989; 244: 811-3.
29. 28 Lewis HM, Baker BS, Bokth S et al. Restricted T cell receptor-Vb gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 1993; 129: 514-20.
30. 29 Robinson JH, Kehoe MA. Group A streptococcal M proteins: virulence factors and protective antigens. Immunol Today 1992; 13: 362-7.
31. 30 Leung DYM, Travers BJ, Giorno R et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995; 96: 2106-12.
32. 31 Chang JC, Smith LR, Froning KJ et al. Persistence of T-cell clones in psoriatic lesions [see comments]. Arch Dermatol 1997; 133: 703-8.
33. 32 Leung DY, Gately M, Trumble A et al. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 1995; 181: 747-53.
34. 33 Valdimarsson H, Sigmundsdottir H, Jonsdottir I. Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin? Clin Exp Immunol 1997; 107 (Suppl. 1): 21-4.
35. 34 Braun MA, Gerlach D, Hartwig UF et al. Stimulation of human T cells by streptococcal 'superantigen' erythrogenic toxins (scarlet fever toxins). J Immunol 1993; 150: 2457-66.